
I am a physician-scientist, a Professor of Medicine, and Director of the Division of Endocrinology, Diabetes, and Metabolism at the Ohio State University Wexner School of Medicine. I am an internist and endocrinologist. The goal of my research career is to define and target the pathways by which obesity and diabetes increase risk of non alcoholic fatty liver disease (NAFLD) and cardiovascular disease. One productive approach my lab has taken is to define the pathways that confer sex differences in dyslipidemia and atherosclerosis with obesity and exercise. We study VLDL production and HDL function and how these change with obesity. We do pre-clinical, translational and clinical research.
Director of the Division of Endocrinology, Diabetes and Metabolism, Professor of Medicine
2025 – present
Associate Professor
2008 – 2025
Medical School
Residency
Fellowship